Cryotherapy in the Treatment of Desmoid Tumors

Condition(s) studied

Investigational drug(s) / intervention(s)

Cryotherapy: The procedure involves general or peripheral anesthesia and percutaneous treatment under CT control with probes capable of forming ice spheres of up to 3 cm that will be used in sufficient number to treat the neoplasm completely.

Study summary

Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.

Eligibility

Primary outcome measure(s)

• response to treatment — At baseline (time 0)
  assessment of tumor response to treatment will be performed using the solid tumor response criteria

Trial sites (1)

More Istituto Ortopedico Rizzoli trials in Italy

Other trials for the same condition